These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 29518251

  • 1. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland.
    Steiner R, Kridel R, Giostra E, McKee T, Achermann R, Mueller N, Manuel O, Dickenmann M, Schuurmans MM, de Leval L, Fehr T, Tinguely M, Binet I, Cogliatti S, Haralamvieva E, Koller M, The Swiss Transplant Cohort Study Stcs, Dietrich PY.
    Swiss Med Wkly; 2018; 148():w14596. PubMed ID: 29518251
    [Abstract] [Full Text] [Related]

  • 2. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    OʼRegan JA, Prendeville S, McCaughan JA, Traynor C, OʼBrien FJ, Ward FL, OʼDonovan D, Kennedy C, Berzan E, Kinsella S, Williams Y, OʼKelly P, Deady S, Comber H, Leader M, Conlon PJ.
    Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients.
    Morton M, Coupes B, Roberts SA, Klapper PE, Byers RJ, Vallely PJ, Ryan K, Picton ML.
    Transplantation; 2013 Feb 15; 95(3):470-8. PubMed ID: 23222821
    [Abstract] [Full Text] [Related]

  • 4. Incidence of post-transplantation lymphoproliferative disease in Andalusia (1990-2009).
    Govantes MA, Esteve AF, Ramos MT, Gracia De Guindo MC, Sánchez LF, Blanca MA, Rodríguez-Benot A, Blandino MV, De la Nuez PC, Rodríguez DB.
    Transplant Proc; 2013 Feb 15; 45(10):3592-4. PubMed ID: 24314968
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
    Rouphael B, Lankireddy S, Lazaryan A, Kukla A, Ibrahim HN, Matas AJ, Issa N.
    Clin Transplant; 2016 Jan 15; 30(1):60-5. PubMed ID: 26497471
    [Abstract] [Full Text] [Related]

  • 6. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct 15; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 7. Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.
    Kremer BE, Reshef R, Misleh JG, Christie JD, Ahya VN, Blumenthal NP, Kotloff RM, Hadjiliadis D, Stadtmauer EA, Schuster SJ, Tsai DE.
    J Heart Lung Transplant; 2012 Mar 15; 31(3):296-304. PubMed ID: 22112992
    [Abstract] [Full Text] [Related]

  • 8. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.
    Reams BD, McAdams HP, Howell DN, Steele MP, Davis RD, Palmer SM.
    Chest; 2003 Oct 15; 124(4):1242-9. PubMed ID: 14555552
    [Abstract] [Full Text] [Related]

  • 9. Incidence and outcomes of post-transplant lymphoproliferative disease after 5365 solid-organ transplants over a 20-year period at two UK transplant centres.
    Santarsieri A, Rudge JF, Amin I, Gelson W, Parmar J, Pettit S, Sharkey L, Uttenthal BJ, Follows GA.
    Br J Haematol; 2022 May 15; 197(3):310-319. PubMed ID: 35235680
    [Abstract] [Full Text] [Related]

  • 10. Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study.
    Francis A, Johnson DW, Teixeira-Pinto A, Craig JC, Wong G.
    Nephrol Dial Transplant; 2018 May 01; 33(5):881-889. PubMed ID: 29342279
    [Abstract] [Full Text] [Related]

  • 11. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 01; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 12. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience.
    Jain A, Nalesnik M, Reyes J, Pokharna R, Mazariegos G, Green M, Eghtesad B, Marsh W, Cacciarelli T, Fontes P, Abu-Elmagd K, Sindhi R, Demetris J, Fung J.
    Ann Surg; 2002 Oct 01; 236(4):429-36; discussion 436-7. PubMed ID: 12368671
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 01; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 14. Is there a difference in post-transplant lymphoproliferative disorder in adults after solid organ and haematologic stem cell transplantation? Experience in 41 patients.
    Tai R, Tirumani SH, Tirumani H, Shinagare AB, Hornick JL, Ramaiya NH.
    Br J Radiol; 2015 Aug 01; 88(1052):20140861. PubMed ID: 25989696
    [Abstract] [Full Text] [Related]

  • 15. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
    Kasiske BL, Kukla A, Thomas D, Wood Ives J, Snyder JJ, Qiu Y, Peng Y, Dharnidharka VR, Israni AK.
    Am J Kidney Dis; 2011 Dec 01; 58(6):971-80. PubMed ID: 21930332
    [Abstract] [Full Text] [Related]

  • 16. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.
    Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, Morelon E, Moal V, Janbon B, Alamartine E, Pouteil Noble C, Morel D, Kamar N, Buchler M, Mamzer MF, Peraldi MN, Hiesse C, Renoult E, Toupance O, Rerolle JP, Delmas S, Lang P, Lebranchu Y, Heng AE, Rebibou JM, Mousson C, Glotz D, Rivalan J, Thierry A, Etienne I, Moal MC, Albano L, Subra JF, Ouali N, Westeel PF, Delahousse M, Genin R, Hurault de Ligny B, Moulin B.
    J Clin Oncol; 2013 Apr 01; 31(10):1302-9. PubMed ID: 23423742
    [Abstract] [Full Text] [Related]

  • 17. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center.
    Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA.
    Transplantation; 1993 Jul 01; 56(1):88-96. PubMed ID: 8333073
    [Abstract] [Full Text] [Related]

  • 18. First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.
    Martínez-Calle N, Alfonso A, Rifón J, Herrero I, Errasti P, Rábago G, Merino J, Panizo Á, Pardo J, Prósper F, García-Muñoz R, Lecumberri R, Panizo C.
    Eur J Haematol; 2017 Jan 01; 98(1):38-43. PubMed ID: 27232286
    [Abstract] [Full Text] [Related]

  • 19. Clinical characteristics of monomorphic post-transplant lymphoproliferative disorders.
    Choi JH, Park BB, Suh C, Won JH, Lee WS, Shin HJ.
    J Korean Med Sci; 2010 Apr 01; 25(4):523-6. PubMed ID: 20357991
    [Abstract] [Full Text] [Related]

  • 20. Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.
    Maksten EF, Vase MØ, Kampmann J, d'Amore F, Møller MB, Strandhave C, Bendix K, Bistrup C, Thiesson HC, Søndergaard E, Hamilton-Dutoit S, Jespersen B.
    Transpl Int; 2016 Apr 01; 29(4):483-93. PubMed ID: 26749337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.